Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse

Abstract

The great majority of patients with remission of MDD after treatment with fluoxetine continue to experience selected residual depressive symptoms. The presence of residual symptoms is not significantly associated with an increased risk of relapse.